Patient Experience Captured by Quality-of-Life Measurement in Oncology Clinical Trials.

ABSTRACT: Importance:Quality of life (QoL) is an important consideration in cancer medicine, especially because drugs are becoming more costly and may only result in modest gains in overall survival. However, there has been no descriptive analysis for the points at which QoL is measured in cancer trials. Objective:To estimate the prevalence of studies that measure QoL at different points and see how many studies measure QoL for the entirety of a patient's life. Design, Setting, and Participants:This cross-sectional analysis includes all articles on oncology clinical trials in the 3 highest-impact oncology journals, published between July 2015 and June 2018, that reported QoL outcomes. Main Outcomes and Measures:Data were abstracted on when QoL was assessed and the characteristics of these studies. R

SUBMITTER: Haslam A 

PROVIDER: S-EPMC7057133 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature